Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today reported financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback